Asia Pacific Preventive Vaccines Market was valued at US$ 20.9 billion in 2023 and is projected to surpass the market valuation of US$ 63.11 billion by 2032 at a CAGR of 13.07% during the forecast period 2024–2032.
Global Regenerative Medicine Market was valued at US$ 59.68 billion in 2023 and is projected to reach a valuation of US$ 472.95 billion by 2032 at a CAGR of 25.86% during the forecast period 2024–2032.
The Global Circulating Tumor Cells Market was valued at US$ 9.5 billion in 2023 and is projected to surpass the market size of US$ 19.0 billion by 2032 at a CAGR of 8.06% during the forecast period 2024–2032.
Global Liposome Development Service Market was valued at US$ 2,322.9 million in 2023 and is projected to attain a market size of US$ 5,016.0 million by 2032 at a CAGR of 8.93% during the forecast period 2024–2032.
Global Clinical Trials Support Service Market was valued at US$ 25.2 billion in 2023 and is projected to surpass US$ 47.1 billion by 2032 at a CAGR of 7.22% during the forecast period 2024–2032.
The Global Hand, Foot, and Mouth Disease Treatment Market was valued at US$ 3,037.3 million in 2023 and is projected to generate a revenue of US$ 5,175.1 million by 2032 at a CAGR of 6.1% during the forecast period 2024–2032.
Global plant stem cells market was valued at US$ 371.4 million in 2022 and is projected to attain a valuation of US$ 801.9 million by 2031 at a CAGR of 8.93% during the forecast period 2023-2031.
United States liquid biopsy market was valued at US$ 3,405.8 million in 2022 and is projected to surpass market valuation of US$ 10,798 million by 2031 at a CAGR of 13.68% during the forecast period 2023–2031.
The global deuterated drugs market, valued at US$ 334.0 million in 2023, presents a robust growth pattern. With a projected valuation of US$ 871.8 million by 2032 at a CAGR of 11.25%, the market is driven by primary drugs including Austedo and Zepsun, used to treat Huntington's Disease (HD), Tardive Dyskinesia (TD), Cancer, and others.